BostonGene
BostonGene is dedicated to advancing precision medicine through innovative AI-powered molecular and immune profiling solutions. They collaborate with leading cancer centers and pharmaceutical companies to improve patient outcomes, support drug development, and transform cancer care with a focus on personalized treatment strategies.
Industries
Nr. of Employees
large (251-1000)
BostonGene
Products
Integrated tumor profiling test (multiomic + immune)
An integrated clinical/research test that combines genomic, transcriptomic, proteomic and immune profiling to characterize tumor drivers, microenvironment features and actionable biomarkers.
Image and AI analytics product for pathology
Software and validated algorithms for pathology image analysis that support biomarker extraction and integration with molecular data.
Integrated tumor profiling test (multiomic + immune)
An integrated clinical/research test that combines genomic, transcriptomic, proteomic and immune profiling to characterize tumor drivers, microenvironment features and actionable biomarkers.
Image and AI analytics product for pathology
Software and validated algorithms for pathology image analysis that support biomarker extraction and integration with molecular data.
Services
Multimodal molecular and immune profiling laboratory services
Comprehensive laboratory analysis combining sequencing, proteomics, flow cytometry and spatial imaging to generate molecular and immune profiles for clinical and research use.
AI-driven oncology analytics and multimodal platform access
Cloud-hosted analytics and AI models that integrate omics, imaging and clinical data to support target identification, patient stratification, and trial optimization.
Clinical trial biomarker and analytics support
Support for clinical trials including biomarker discovery, responder‑cohort identification, data delivery and regulatory‑aligned documentation.
Digital pathology and image analysis services
Whole‑slide image analysis, annotation, and development of image-based biomarkers using deep learning and computer vision pipelines.
Immune profiling from blood
High‑dimensional immune cell typing and immunophenotyping from blood samples using flow cytometry/CyTOF and computational analysis to identify immunotypes and biomarkers.
Liquid biopsy genomic profiling
cfDNA and cfRNA testing workflows to profile tumor genetics non‑invasively for cases where tissue is unavailable.
Multimodal molecular and immune profiling laboratory services
Comprehensive laboratory analysis combining sequencing, proteomics, flow cytometry and spatial imaging to generate molecular and immune profiles for clinical and research use.
AI-driven oncology analytics and multimodal platform access
Cloud-hosted analytics and AI models that integrate omics, imaging and clinical data to support target identification, patient stratification, and trial optimization.
Clinical trial biomarker and analytics support
Support for clinical trials including biomarker discovery, responder‑cohort identification, data delivery and regulatory‑aligned documentation.
Digital pathology and image analysis services
Whole‑slide image analysis, annotation, and development of image-based biomarkers using deep learning and computer vision pipelines.
Immune profiling from blood
High‑dimensional immune cell typing and immunophenotyping from blood samples using flow cytometry/CyTOF and computational analysis to identify immunotypes and biomarkers.
Liquid biopsy genomic profiling
cfDNA and cfRNA testing workflows to profile tumor genetics non‑invasively for cases where tissue is unavailable.
Expertise Areas
- Clinical trial management and stratification
- Multimodal biomarker discovery and validation
- Digital pathology and computational histopathology
- Immune profiling and computational immunology
Key Technologies
- Next‑generation sequencing (WES/WTS)
- cfDNA / cfRNA liquid biopsy sequencing
- Single‑cell RNA sequencing
- TCR/BCR repertoire sequencing